Lanzogerd DT is a Lansoprazole 15mg Orally Disintegrating Tablet (ODT) formulated specifically for children and patients who have difficulty swallowing conventional tablets.

It is prescribed by healthcare professionals for Gastroesophageal Reflux Disease (GERD), erosive esophagitis, heartburn, acid-related gastric disorders, and pediatric GERD manifestations such as Sandifer syndrome, excessive crying, sleep disturbance, apnea episodes, laryngospasm, and recurrent pneumonia.

• Lansoprazole 15mg
• Orally Disintegrating Tablet (ODT) — Strawberry Flavour
• 24-Hour Acid Reducer
• Melts in the mouth without water

Lansoprazole is a Proton Pump Inhibitor (PPI) that works by blocking the proton pumps in the stomach lining — the final step in gastric acid production.

This significantly reduces the amount of acid produced, providing relief from heartburn, reflux, and acid-related damage to the esophagus, and delivering effective 24-hour acid control.

ODT (Orally Disintegrating Tablet) means the tablet dissolves instantly on the tongue without needing water. This makes it especially valuable for infants, young children, and patients who cannot swallow tablets.

The strawberry-flavoured formulation also improves palatability, making it easier for children to take the medicine without resistance, leading to better treatment compliance.

GERD (Gastroesophageal Reflux Disease) occurs when stomach acid flows back into the esophagus, causing irritation and damage. In children, it can present as Sandifer syndrome (arching and dystonia-like episodes), excessive crying (often misdiagnosed as colic), or sleep disturbances.

If left untreated, GERD can lead to poor weight gain, laryngospasm, recurrent pneumonia, apnea episodes in neonates, and esophageal damage. Early control of reflux supports better beginnings for life.

Lanzogerd DT is indicated for pediatric patients aged 1 to 17 years for short-term treatment of symptomatic GERD and erosive esophagitis, as well as for adults.

It is not recommended for children below 1 year of age, as safety and efficacy have not been established in that age group. The dosage is weight-based: 15mg daily for children weighing 30kg or less, and 30mg daily for those above 30kg, as prescribed by a doctor.

Place the tablet on the tongue and allow it to dissolve into particles — with or without water. Swallow the dissolved particles immediately. Do not crush, chew, or break the tablet before placing it on the tongue.

For administration via oral syringe: place the 15mg tablet in the syringe, add 4ml of water, shake gently until dissolved, and administer within 15 minutes. Always keep hands dry before handling the tablet.

Lanzogerd DT is generally recommended to be taken before meals — ideally 30 minutes before eating — for best efficacy.

Always follow the exact schedule and instructions provided by your healthcare professional.

For children aged 1–11 years, treatment is typically prescribed for up to 12 weeks. For adolescents (12–17 years) and adults, treatment is typically up to 8 weeks for GERD and erosive esophagitis.

Do not exceed the recommended duration without consulting your doctor. Do not stop the medication early without medical advice, as symptoms may return.

No. Lanzogerd DT should be used only under medical supervision, particularly in pediatric patients.

Your doctor will determine the correct dose and duration based on the child's age, weight, symptoms, and clinical condition. It is advisable to stop this medicine at least 3 days before undergoing any allergy or gastric function tests.

Caution is advised in patients with liver disease, osteoporosis risk (long-term PPI use may affect bone density), low magnesium levels, or those taking interacting medicines.

Lanzogerd DT is not recommended for children below 1 year of age due to risk of heart valve thickening. Pregnant or breastfeeding women should use it only if specifically advised by a healthcare professional.

Yes. Lansoprazole may interact with antifungals, certain antibiotics (amoxicillin, clarithromycin), anticoagulants like warfarin, methotrexate, and medicines that depend on stomach acid for absorption.

Inform your doctor about all medicines, supplements, and herbal products your child or you are currently taking before starting Lanzogerd DT.

Common side effects may include diarrhea, abdominal pain, nausea, constipation, headache, and upper respiratory tract infections.

Rare but serious effects include severe allergic reactions, low magnesium levels (with prolonged use), and Clostridium difficile-associated diarrhea. Contact a healthcare professional immediately if symptoms are severe, persistent, or unusual.

Lanzogerd DT uses a delayed-release orally disintegrating technology — the tablet dissolves on the tongue instantly while the Lansoprazole granules within are enteric-coated to protect the acid-sensitive drug from stomach acid until it reaches the small intestine for absorption.

The strawberry flavour and large 150-tablet pack (10×15) ensure child-friendly compliance and uninterrupted therapy.

Lanzogerd DT tablets are manufactured with controlled enteric coating of Lansoprazole granules, disintegration time testing, tablet weight uniformity, and dissolution profile checks.

Quality assessment includes assay, stability, moisture control, flavour uniformity, and batch-to-batch consistency as applicable.

Store at room temperature between 15–25°C in a dry place. Keep away from direct sunlight, heat, and moisture.

Keep hands dry before handling tablets. Keep out of reach of children. Do not use after the expiry date printed on the pack.

• Lanzogerd DT — Lansoprazole 15mg Orally Disintegrating Tablets
• Strawberry Flavour | 24-Hour Acid Reducer
• Pack: 150 Tablets (10×15 Tablets)
• Manufactured by Santheras